Covenant Asset Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-794
Closed -$225K 136
2021
Q3
$225K Hold
794
0.07% 127
2021
Q2
$275K Hold
794
0.08% 122
2021
Q1
$222K Buy
+794
New +$214K 0.07% 135
2020
Q4
Sell
-8,364
Closed -$2.16M 137
2020
Q3
$2.37M Sell
8,364
-104
-1% -$29K 0.76% 38
2020
Q2
$2.27M Buy
8,468
+282
+3% +$84.8K 0.5% 44
2020
Q1
$2.59M Sell
8,186
-8
-0.1% -$2.43K 0.78% 25
2019
Q4
$2.43M Buy
8,194
+5,608
+217% +$1.56M 1.06% 32
2019
Q3
$602K Sell
2,586
-161
-6% -$37.5K 0.3% 81
2019
Q2
$642K Sell
2,747
-2,308
-46% -$533K 0.33% 81
2019
Q1
$1.2M Sell
5,055
-185
-4% -$58.3K 0.63% 54
2018
Q4
$1.85M Hold
5,240
0.93% 39
2018
Q3
$1.85M Hold
5,240
0.93% 39
2018
Q2
$1.52M Sell
5,240
-340
-6% -$95.6K 0.82% 45
2018
Q1
$1.53M Sell
5,580
-230
-4% -$71.4K 0.88% 45
2017
Q4
$1.85M Sell
5,810
-50
-0.9% -$16K 1.08% 33
2017
Q3
$1.83M Sell
5,860
-100
-2% -$29.6K 1.12% 30
2017
Q2
$1.62M Sell
5,960
-650
-10% -$172K 1.03% 34
2017
Q1
$1.81M Sell
6,610
-6,218
-48% -$1.76M 1.22% 30
2016
Q4
$3.64M Buy
+12,828
New +$3.8M 2.44% 5

Other funds holding BIIB

Covenant Asset Management's BIIB Position: Q4 2021 in Review

Covenant Asset Management sold out of Biogen (BIIB) in Q4 2021, closing a stake of 794 shares — an estimated $225K sold.

Covenant Asset Management first reported a position in BIIB in Q4 2016 and held it in 19 quarters. The position peaked at $3.64M in Q4 2016. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

  • Covenant Asset Management reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
  • Covenant Asset Management sold 794 Biogen shares in Q4 2021, an estimated $225K.
  • Covenant Asset Management first reported a position in Biogen in Q4 2016 and held it in 19 quarters.
  • Covenant Asset Management's Biogen position peaked at $3.64M in Q4 2016.
  • 1,009 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Covenant Asset Management's 13F filing for Q4 2021, filed 26 Jan 2022.